Melissa Dupree is named as a lobbyist on federal disclosure filings for 38 clients through Fabiani & Company and 1 other registrant. The most recent filing naming them posted in April 2014. Issues reported include Health Issues, Medical/Disease Research/Clinical Labs, Defense and Budget/Appropriations.
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| NANOTHERAPEUTICS, INC. | THE CONAFAY GROUP, LLC | Q1 2014 | Defense, Medical/Disease Research/Clinical Labs |
| CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP | THE CONAFAY GROUP, LLC | Q4 2013 | Medical/Disease Research/Clinical Labs |
| ACORDA THERAPEUTICS, INC. | FABIANI & COMPANY | Q3 2013 | Medical/Disease Research/Clinical Labs, Health Issues, Pharmacy |
| CONAFAY GROUP LLC ON BEHALF OF MEDICAGO | THE CONAFAY GROUP, LLC | Q2 2013 | Medical/Disease Research/Clinical Labs |
| ZIOPHARM ONCOLOGY, INC. | THE CONAFAY GROUP, LLC | Q1 2013 | Medical/Disease Research/Clinical Labs |
| REMPEX PHARMACEUTICALS, INC. | THE CONAFAY GROUP, LLC | Q4 2012 | Medical/Disease Research/Clinical Labs |
| OCERA THERAPEUTICS INC. | FABIANI & COMPANY | Q4 2009 | Defense, Budget/Appropriations, Health Issues |
| MEDICAGO INC. | FABIANI & COMPANY | Q4 2012 | Defense, Medical/Disease Research/Clinical Labs, Health Issues |
| ASURAGEN, INC. | FABIANI & COMPANY | Q4 2012 | Medical/Disease Research/Clinical Labs, Health Issues |
| SIALIX INC. | FABIANI & COMPANY | Q4 2012 | Medical/Disease Research/Clinical Labs, Health Issues |
| REMPEX PHARMACEUTICALS, INC. | FABIANI & COMPANY | Q4 2012 | Medical/Disease Research/Clinical Labs, Health Issues |
| AURA BIOSCIENCES | FABIANI & COMPANY | Q4 2012 | Medical/Disease Research/Clinical Labs, Health Issues |
| TETRAPHASE PHARMACEUTICALS | FABIANI & COMPANY | Q2 2012 | Veterans, Defense, Health Issues |
| SANOVAS INC. | FABIANI & COMPANY | Q1 2012 | Science/Technology, Medical/Disease Research/Clinical Labs, Health Issues |
| HEAT BIOLOGICS | FABIANI & COMPANY | Q1 2012 | Medical/Disease Research/Clinical Labs |
| ALNYLAM PHARMACEUTICALS | FABIANI & COMPANY | Q1 2012 | Medical/Disease Research/Clinical Labs, Copyright/Patent/Trademark, Health Issues |
| ANTHERA PHARMACEUTICALS, INC. | FABIANI & COMPANY | Q1 2012 | Medical/Disease Research/Clinical Labs, Health Issues |
| AETHLON MEDICAL, INC. | FABIANI & COMPANY | Q3 2011 | Defense, Health Issues |
| TRIUS THERAPEUTICS | FABIANI & COMPANY | Q4 2011 | Health Issues |
| KENNEDY KRIEGER INSTITUTE | FABIANI & COMPANY | Q4 2011 | Medical/Disease Research/Clinical Labs |
| IPIERIAN, INC. | FABIANI & COMPANY | Q2 2011 | Veterans, Defense, Medical/Disease Research/Clinical Labs |
| CONCERT PHARMACEUTICALS, INC. | FABIANI & COMPANY | Q3 2011 | Medical/Disease Research/Clinical Labs, Budget/Appropriations |
| AUBURN UNIVERSITY | FABIANI & COMPANY | Q3 2011 | Animals, Medical/Disease Research/Clinical Labs, Health Issues |
| ZIOPHARM ONCOLOGY, INC. | FABIANI & COMPANY | Q2 2011 | Medical/Disease Research/Clinical Labs, Health Issues |
| CLINICAL DATA INC | FABIANI & COMPANY | Q1 2011 | Science/Technology, Medical/Disease Research/Clinical Labs, Budget/Appropriations |
| BIOJECT MEDICAL TECHNOLOGIES INC. | FABIANI & COMPANY | Q1 2011 | Defense, Medical/Disease Research/Clinical Labs, Science/Technology |
| ARCA BIOPHARMA, INC. | FABIANI & COMPANY | Q1 2011 | Veterans, Defense, Health Issues |
| VARIATION BIOTECHNOLOGIES (US), INC. | FABIANI & COMPANY | Q4 2010 | Defense, Medical/Disease Research/Clinical Labs, Health Issues |
| PRIMERADX | FABIANI & COMPANY | Q3 2010 | Defense, Medical/Disease Research/Clinical Labs, Budget/Appropriations |
| OHMX CORPORATION | FABIANI & COMPANY | Q4 2010 | Medical/Disease Research/Clinical Labs, Budget/Appropriations |
| NANOTHERAPEUTICS INC | FABIANI & COMPANY | Q4 2009 | Defense, Budget/Appropriations, Health Issues |
| CODA THERAPEUTICS, INC. | FABIANI & COMPANY | Q1 2010 | Defense, Medical/Disease Research/Clinical Labs, Budget/Appropriations |
| CEMPRA PHARMACEUTICALS INC. | FABIANI & COMPANY | Q1 2010 | Science/Technology, Medical/Disease Research/Clinical Labs, Budget/Appropriations |
| CRESTONE, INC. | FABIANI & COMPANY | Q1 2010 | Defense, Health Issues |
| ARSENAL MEDICAL | FABIANI & COMPANY | Q4 2009 | Medical/Disease Research/Clinical Labs |
| THEROX, INC. | FABIANI & COMPANY | Q4 2009 | Defense, Health Issues |
| PLANET BIOTECHNOLOGY INC | FABIANI & COMPANY | Q4 2009 | Defense, Budget/Appropriations, Health Issues |
| 3-V BIOSCIENCES, INC. | FABIANI & COMPANY | Q4 2009 | Defense, Health Issues |
| SPALTUDAQ CORPORATION | FABIANI & COMPANY | Q2 2009 | Medical/Disease Research/Clinical Labs, Health Issues, Homeland Security |
| THERAPURE BIOPHARMA, INC. | FABIANI & COMPANY | Q1 2009 | Defense, Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2014 | 1 | 1 |
| 2013 | 3 | 2 |
| 2012 | 11 | 1 |
| 2011 | 14 | 1 |
| 2010 | 16 | 1 |
| 2009 | 16 | 1 |
| 2008 | 6 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Melissa Dupree. See the Capitol Clarity rankings and method.